2American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm, 1990,47:1 033-1 034. 被引量：1
3Occupational Safety and Health Administration U.S. Department of Labor. Technical Links>Osha Technical Manual. Controlling occupational exposure to hazardous drugs. 1993. 被引量：1
4Zimmerman PF, Larsen RK, Barkley EW, et al. Recommendations for the safe handling of injectable antineoplastic drug products. Am J Hosp Pharm, 1981, 38:1 693-1 695. 被引量：1
5Falck K, Grohn P, Sorsa M, et al. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet, 1979, 1: 1 250-1 251. 被引量：1
6Michael A, Mattia SLB. Hospital hazards-Cancer drugs. Am J Nursing, 1983,5:758-759. 被引量：1
7Rogers B, Emmett EA. Handling antineoplastic agents: urine mutagenicity in nurses. IMAGE Journal of Nursing Scholarship, 1987, 19:108-113. 被引量：1
8Anderson RW, Puckett WH, Dana WJ, et al. Risk of handling injectable antineoplastic agents. Am J Hosp Pharm, 1982,39:1 881-1 887. 被引量：1
9Bruce RH. Developing guidelines for working with antineoplastic drugs. Am J Hosp Pharm, 1981,38:1 693-1 695. 被引量：1
10Waksvik H, Klepp O. Chromosome analyses of nurses handling cytostatic agents. Cancer Treatment Reports, 1981, 65:607-610. 被引量：1
